{"id":"https://openalex.org/W1979947382","doi":"https://doi.org/10.1089/bsp.2012.0062","title":"Differentiating Microbial Forensic qPCR Target and Control Products by Electrospray Ionization Mass Spectrometry","display_name":"Differentiating Microbial Forensic qPCR Target and Control Products by Electrospray Ionization Mass Spectrometry","publication_year":2013,"publication_date":"2013-05-15","ids":{"openalex":"https://openalex.org/W1979947382","doi":"https://doi.org/10.1089/bsp.2012.0062","mag":"1979947382","pmid":"https://pubmed.ncbi.nlm.nih.gov/23675878","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3696942"},"language":"en","primary_location":{"id":"doi:10.1089/bsp.2012.0062","doi":"https://doi.org/10.1089/bsp.2012.0062","is_oa":true,"landing_page_url":"https://doi.org/10.1089/bsp.2012.0062","pdf_url":null,"source":{"id":"https://openalex.org/S167979021","display_name":"Biosecurity and Bioterrorism Biodefense Strategy Practice and Science","issn_l":"1538-7135","issn":["1538-7135","1557-850X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","jufo-1","norway-1"],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biosecurity and Bioterrorism: Biodefense Strategy, Practice, and Science","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.1089/bsp.2012.0062","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5102949905","display_name":"S. Timothy Motley","orcid":"https://orcid.org/0000-0001-8655-2487","observed_orcids":["https://orcid.org/0000-0001-8655-2487"]},"institutions":[{"id":"https://openalex.org/I4210088555","display_name":"Abbott (United States)","ror":"https://ror.org/0052svj16","country_code":"US","type":"company","lineage":["https://openalex.org/I4210088555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"S. Timothy Motley","raw_affiliation_strings":["S. Timothy Motley, MS, is Principal Scientist, New Technology Development; Mark W. Eshoo, PhD, is Director, New Technology Development; Kristin A. Sannes-Lowery, PhD, is Director of Commercial Laboratory Operations; and Steven A. Hofstadler, PhD, is Divisional Vice President, Research and Development; all at Ibis Biosciences, Inc., An Abbott Company, Carlsbad, California. Cassie L. Redden, BS, was, at the time this article was written, Research Associate; James P. Burans, PhD, is Director; and M. J. Rosovitz, PhD, is Principal Investigator; all at the National Bioforensic Analysis Center, National Biodefense Analysis and Countermeasures Center, Frederick, Maryland","S. Timothy Motley, MS, is Principal Scientist, New Technology Development; Mark W. Eshoo, PhD, is Director, New Technology Development; Kristin A. Sannes-Lowery, PhD, is Director of Commercial Laboratory Operations; and Steven A. Hofstadler, PhD, is Divisional Vice President, Research and Development; all at Ibis Biosciences, Inc., An Abbott Company, Carlsbad, California. Cassie L. Redden, BS, was, at the time this article was written, Research Associate; James P. Burans, PhD, is Director; and M. J"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"S. Timothy Motley, MS, is Principal Scientist, New Technology Development; Mark W. Eshoo, PhD, is Director, New Technology Development; Kristin A. Sannes-Lowery, PhD, is Director of Commercial Laboratory Operations; and Steven A. Hofstadler, PhD, is Divisional Vice President, Research and Development; all at Ibis Biosciences, Inc., An Abbott Company, Carlsbad, California. Cassie L. Redden, BS, was, at the time this article was written, Research Associate; James P. Burans, PhD, is Director; and M. J. Rosovitz, PhD, is Principal Investigator; all at the National Bioforensic Analysis Center, National Biodefense Analysis and Countermeasures Center, Frederick, Maryland","institution_ids":["https://openalex.org/I4210088555"]},{"raw_affiliation_string":"S. Timothy Motley, MS, is Principal Scientist, New Technology Development; Mark W. Eshoo, PhD, is Director, New Technology Development; Kristin A. Sannes-Lowery, PhD, is Director of Commercial Laboratory Operations; and Steven A. Hofstadler, PhD, is Divisional Vice President, Research and Development; all at Ibis Biosciences, Inc., An Abbott Company, Carlsbad, California. Cassie L. Redden, BS, was, at the time this article was written, Research Associate; James P. Burans, PhD, is Director; and M. J","institution_ids":["https://openalex.org/I4210088555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069128877","display_name":"Cassie L. Redden","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210088555","display_name":"Abbott (United States)","ror":"https://ror.org/0052svj16","country_code":"US","type":"company","lineage":["https://openalex.org/I4210088555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Cassie L. Redden","raw_affiliation_strings":["S. Timothy Motley, MS, is Principal Scientist, New Technology Development; Mark W. Eshoo, PhD, is Director, New Technology Development; Kristin A. Sannes-Lowery, PhD, is Director of Commercial Laboratory Operations; and Steven A. Hofstadler, PhD, is Divisional Vice President, Research and Development; all at Ibis Biosciences, Inc., An Abbott Company, Carlsbad, California. Cassie L. Redden, BS, was, at the time this article was written, Research Associate; James P. Burans, PhD, is Director; and M. J. Rosovitz, PhD, is Principal Investigator; all at the National Bioforensic Analysis Center, National Biodefense Analysis and Countermeasures Center, Frederick, Maryland","National Bioforensic Analysis Center, National Biodefense Analysis and Countermeasures Center, Frederick, Maryland","New Technology Development;","S. Timothy Motley, MS, is Principal Scientist, New Technology Development; Mark W. Eshoo, PhD, is Director, New Technology Development; Kristin A. Sannes-Lowery, PhD, is Director of Commercial Laboratory Operations; and Steven A. Hofstadler, PhD, is Divisional Vice President, Research and Development; all at Ibis Biosciences, Inc., An Abbott Company, Carlsbad, California. Cassie L. Redden, BS, was, at the time this article was written, Research Associate; James P. Burans, PhD, is Director; and M. J"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"S. Timothy Motley, MS, is Principal Scientist, New Technology Development; Mark W. Eshoo, PhD, is Director, New Technology Development; Kristin A. Sannes-Lowery, PhD, is Director of Commercial Laboratory Operations; and Steven A. Hofstadler, PhD, is Divisional Vice President, Research and Development; all at Ibis Biosciences, Inc., An Abbott Company, Carlsbad, California. Cassie L. Redden, BS, was, at the time this article was written, Research Associate; James P. Burans, PhD, is Director; and M. J. Rosovitz, PhD, is Principal Investigator; all at the National Bioforensic Analysis Center, National Biodefense Analysis and Countermeasures Center, Frederick, Maryland","institution_ids":["https://openalex.org/I4210088555"]},{"raw_affiliation_string":"National Bioforensic Analysis Center, National Biodefense Analysis and Countermeasures Center, Frederick, Maryland","institution_ids":[]},{"raw_affiliation_string":"New Technology Development;","institution_ids":[]},{"raw_affiliation_string":"S. Timothy Motley, MS, is Principal Scientist, New Technology Development; Mark W. Eshoo, PhD, is Director, New Technology Development; Kristin A. Sannes-Lowery, PhD, is Director of Commercial Laboratory Operations; and Steven A. Hofstadler, PhD, is Divisional Vice President, Research and Development; all at Ibis Biosciences, Inc., An Abbott Company, Carlsbad, California. Cassie L. Redden, BS, was, at the time this article was written, Research Associate; James P. Burans, PhD, is Director; and M. J","institution_ids":["https://openalex.org/I4210088555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020567318","display_name":"Kristin A. Sannes","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210088555","display_name":"Abbott (United States)","ror":"https://ror.org/0052svj16","country_code":"US","type":"company","lineage":["https://openalex.org/I4210088555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kristin A. Sannes-Lowery","raw_affiliation_strings":["S. Timothy Motley, MS, is Principal Scientist, New Technology Development; Mark W. Eshoo, PhD, is Director, New Technology Development; Kristin A. Sannes-Lowery, PhD, is Director of Commercial Laboratory Operations; and Steven A. Hofstadler, PhD, is Divisional Vice President, Research and Development; all at Ibis Biosciences, Inc., An Abbott Company, Carlsbad, California. Cassie L. Redden, BS, was, at the time this article was written, Research Associate; James P. Burans, PhD, is Director; and M. J. Rosovitz, PhD, is Principal Investigator; all at the National Bioforensic Analysis Center, National Biodefense Analysis and Countermeasures Center, Frederick, Maryland","National Bioforensic Analysis Center, National Biodefense Analysis and Countermeasures Center, Frederick, Maryland","New Technology Development;","S. Timothy Motley, MS, is Principal Scientist, New Technology Development; Mark W. Eshoo, PhD, is Director, New Technology Development; Kristin A. Sannes-Lowery, PhD, is Director of Commercial Laboratory Operations; and Steven A. Hofstadler, PhD, is Divisional Vice President, Research and Development; all at Ibis Biosciences, Inc., An Abbott Company, Carlsbad, California. Cassie L. Redden, BS, was, at the time this article was written, Research Associate; James P. Burans, PhD, is Director; and M. J"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"S. Timothy Motley, MS, is Principal Scientist, New Technology Development; Mark W. Eshoo, PhD, is Director, New Technology Development; Kristin A. Sannes-Lowery, PhD, is Director of Commercial Laboratory Operations; and Steven A. Hofstadler, PhD, is Divisional Vice President, Research and Development; all at Ibis Biosciences, Inc., An Abbott Company, Carlsbad, California. Cassie L. Redden, BS, was, at the time this article was written, Research Associate; James P. Burans, PhD, is Director; and M. J. Rosovitz, PhD, is Principal Investigator; all at the National Bioforensic Analysis Center, National Biodefense Analysis and Countermeasures Center, Frederick, Maryland","institution_ids":["https://openalex.org/I4210088555"]},{"raw_affiliation_string":"National Bioforensic Analysis Center, National Biodefense Analysis and Countermeasures Center, Frederick, Maryland","institution_ids":[]},{"raw_affiliation_string":"New Technology Development;","institution_ids":[]},{"raw_affiliation_string":"S. Timothy Motley, MS, is Principal Scientist, New Technology Development; Mark W. Eshoo, PhD, is Director, New Technology Development; Kristin A. Sannes-Lowery, PhD, is Director of Commercial Laboratory Operations; and Steven A. Hofstadler, PhD, is Divisional Vice President, Research and Development; all at Ibis Biosciences, Inc., An Abbott Company, Carlsbad, California. Cassie L. Redden, BS, was, at the time this article was written, Research Associate; James P. Burans, PhD, is Director; and M. J","institution_ids":["https://openalex.org/I4210088555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112464011","display_name":"Mark W. Eshoo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210088555","display_name":"Abbott (United States)","ror":"https://ror.org/0052svj16","country_code":"US","type":"company","lineage":["https://openalex.org/I4210088555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mark W. Eshoo","raw_affiliation_strings":["S. Timothy Motley, MS, is Principal Scientist, New Technology Development; Mark W. Eshoo, PhD, is Director, New Technology Development; Kristin A. Sannes-Lowery, PhD, is Director of Commercial Laboratory Operations; and Steven A. Hofstadler, PhD, is Divisional Vice President, Research and Development; all at Ibis Biosciences, Inc., An Abbott Company, Carlsbad, California. Cassie L. Redden, BS, was, at the time this article was written, Research Associate; James P. Burans, PhD, is Director; and M. J. Rosovitz, PhD, is Principal Investigator; all at the National Bioforensic Analysis Center, National Biodefense Analysis and Countermeasures Center, Frederick, Maryland","National Bioforensic Analysis Center, National Biodefense Analysis and Countermeasures Center, Frederick, Maryland","New Technology Development;","S. Timothy Motley, MS, is Principal Scientist, New Technology Development; Mark W. Eshoo, PhD, is Director, New Technology Development; Kristin A. Sannes-Lowery, PhD, is Director of Commercial Laboratory Operations; and Steven A. Hofstadler, PhD, is Divisional Vice President, Research and Development; all at Ibis Biosciences, Inc., An Abbott Company, Carlsbad, California. Cassie L. Redden, BS, was, at the time this article was written, Research Associate; James P. Burans, PhD, is Director; and M. J"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"S. Timothy Motley, MS, is Principal Scientist, New Technology Development; Mark W. Eshoo, PhD, is Director, New Technology Development; Kristin A. Sannes-Lowery, PhD, is Director of Commercial Laboratory Operations; and Steven A. Hofstadler, PhD, is Divisional Vice President, Research and Development; all at Ibis Biosciences, Inc., An Abbott Company, Carlsbad, California. Cassie L. Redden, BS, was, at the time this article was written, Research Associate; James P. Burans, PhD, is Director; and M. J. Rosovitz, PhD, is Principal Investigator; all at the National Bioforensic Analysis Center, National Biodefense Analysis and Countermeasures Center, Frederick, Maryland","institution_ids":["https://openalex.org/I4210088555"]},{"raw_affiliation_string":"National Bioforensic Analysis Center, National Biodefense Analysis and Countermeasures Center, Frederick, Maryland","institution_ids":[]},{"raw_affiliation_string":"New Technology Development;","institution_ids":[]},{"raw_affiliation_string":"S. Timothy Motley, MS, is Principal Scientist, New Technology Development; Mark W. Eshoo, PhD, is Director, New Technology Development; Kristin A. Sannes-Lowery, PhD, is Director of Commercial Laboratory Operations; and Steven A. Hofstadler, PhD, is Divisional Vice President, Research and Development; all at Ibis Biosciences, Inc., An Abbott Company, Carlsbad, California. Cassie L. Redden, BS, was, at the time this article was written, Research Associate; James P. Burans, PhD, is Director; and M. J","institution_ids":["https://openalex.org/I4210088555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036377903","display_name":"Steven A. Hofstadler","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210088555","display_name":"Abbott (United States)","ror":"https://ror.org/0052svj16","country_code":"US","type":"company","lineage":["https://openalex.org/I4210088555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Steven A. Hofstadler","raw_affiliation_strings":["S. Timothy Motley, MS, is Principal Scientist, New Technology Development; Mark W. Eshoo, PhD, is Director, New Technology Development; Kristin A. Sannes-Lowery, PhD, is Director of Commercial Laboratory Operations; and Steven A. Hofstadler, PhD, is Divisional Vice President, Research and Development; all at Ibis Biosciences, Inc., An Abbott Company, Carlsbad, California. Cassie L. Redden, BS, was, at the time this article was written, Research Associate; James P. Burans, PhD, is Director; and M. J. Rosovitz, PhD, is Principal Investigator; all at the National Bioforensic Analysis Center, National Biodefense Analysis and Countermeasures Center, Frederick, Maryland","National Bioforensic Analysis Center, National Biodefense Analysis and Countermeasures Center, Frederick, Maryland","New Technology Development;","S. Timothy Motley, MS, is Principal Scientist, New Technology Development; Mark W. Eshoo, PhD, is Director, New Technology Development; Kristin A. Sannes-Lowery, PhD, is Director of Commercial Laboratory Operations; and Steven A. Hofstadler, PhD, is Divisional Vice President, Research and Development; all at Ibis Biosciences, Inc., An Abbott Company, Carlsbad, California. Cassie L. Redden, BS, was, at the time this article was written, Research Associate; James P. Burans, PhD, is Director; and M. J"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"S. Timothy Motley, MS, is Principal Scientist, New Technology Development; Mark W. Eshoo, PhD, is Director, New Technology Development; Kristin A. Sannes-Lowery, PhD, is Director of Commercial Laboratory Operations; and Steven A. Hofstadler, PhD, is Divisional Vice President, Research and Development; all at Ibis Biosciences, Inc., An Abbott Company, Carlsbad, California. Cassie L. Redden, BS, was, at the time this article was written, Research Associate; James P. Burans, PhD, is Director; and M. J. Rosovitz, PhD, is Principal Investigator; all at the National Bioforensic Analysis Center, National Biodefense Analysis and Countermeasures Center, Frederick, Maryland","institution_ids":["https://openalex.org/I4210088555"]},{"raw_affiliation_string":"National Bioforensic Analysis Center, National Biodefense Analysis and Countermeasures Center, Frederick, Maryland","institution_ids":[]},{"raw_affiliation_string":"New Technology Development;","institution_ids":[]},{"raw_affiliation_string":"S. Timothy Motley, MS, is Principal Scientist, New Technology Development; Mark W. Eshoo, PhD, is Director, New Technology Development; Kristin A. Sannes-Lowery, PhD, is Director of Commercial Laboratory Operations; and Steven A. Hofstadler, PhD, is Divisional Vice President, Research and Development; all at Ibis Biosciences, Inc., An Abbott Company, Carlsbad, California. Cassie L. Redden, BS, was, at the time this article was written, Research Associate; James P. Burans, PhD, is Director; and M. J","institution_ids":["https://openalex.org/I4210088555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112164834","display_name":"James P. Burans","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210088555","display_name":"Abbott (United States)","ror":"https://ror.org/0052svj16","country_code":"US","type":"company","lineage":["https://openalex.org/I4210088555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"James P. Burans","raw_affiliation_strings":["S. Timothy Motley, MS, is Principal Scientist, New Technology Development; Mark W. Eshoo, PhD, is Director, New Technology Development; Kristin A. Sannes-Lowery, PhD, is Director of Commercial Laboratory Operations; and Steven A. Hofstadler, PhD, is Divisional Vice President, Research and Development; all at Ibis Biosciences, Inc., An Abbott Company, Carlsbad, California. Cassie L. Redden, BS, was, at the time this article was written, Research Associate; James P. Burans, PhD, is Director; and M. J. Rosovitz, PhD, is Principal Investigator; all at the National Bioforensic Analysis Center, National Biodefense Analysis and Countermeasures Center, Frederick, Maryland","National Bioforensic Analysis Center, National Biodefense Analysis and Countermeasures Center, Frederick, Maryland","New Technology Development;","S. Timothy Motley, MS, is Principal Scientist, New Technology Development; Mark W. Eshoo, PhD, is Director, New Technology Development; Kristin A. Sannes-Lowery, PhD, is Director of Commercial Laboratory Operations; and Steven A. Hofstadler, PhD, is Divisional Vice President, Research and Development; all at Ibis Biosciences, Inc., An Abbott Company, Carlsbad, California. Cassie L. Redden, BS, was, at the time this article was written, Research Associate; James P. Burans, PhD, is Director; and M. J"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"S. Timothy Motley, MS, is Principal Scientist, New Technology Development; Mark W. Eshoo, PhD, is Director, New Technology Development; Kristin A. Sannes-Lowery, PhD, is Director of Commercial Laboratory Operations; and Steven A. Hofstadler, PhD, is Divisional Vice President, Research and Development; all at Ibis Biosciences, Inc., An Abbott Company, Carlsbad, California. Cassie L. Redden, BS, was, at the time this article was written, Research Associate; James P. Burans, PhD, is Director; and M. J. Rosovitz, PhD, is Principal Investigator; all at the National Bioforensic Analysis Center, National Biodefense Analysis and Countermeasures Center, Frederick, Maryland","institution_ids":["https://openalex.org/I4210088555"]},{"raw_affiliation_string":"National Bioforensic Analysis Center, National Biodefense Analysis and Countermeasures Center, Frederick, Maryland","institution_ids":[]},{"raw_affiliation_string":"New Technology Development;","institution_ids":[]},{"raw_affiliation_string":"S. Timothy Motley, MS, is Principal Scientist, New Technology Development; Mark W. Eshoo, PhD, is Director, New Technology Development; Kristin A. Sannes-Lowery, PhD, is Director of Commercial Laboratory Operations; and Steven A. Hofstadler, PhD, is Divisional Vice President, Research and Development; all at Ibis Biosciences, Inc., An Abbott Company, Carlsbad, California. Cassie L. Redden, BS, was, at the time this article was written, Research Associate; James P. Burans, PhD, is Director; and M. J","institution_ids":["https://openalex.org/I4210088555"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5108486275","display_name":"M. J. Rosovitz","orcid":"https://orcid.org/0009-0007-1639-3370","observed_orcids":["https://orcid.org/0009-0007-1639-3370"]},"institutions":[{"id":"https://openalex.org/I4210088555","display_name":"Abbott (United States)","ror":"https://ror.org/0052svj16","country_code":"US","type":"company","lineage":["https://openalex.org/I4210088555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. J. Rosovitz","raw_affiliation_strings":["S. Timothy Motley, MS, is Principal Scientist, New Technology Development; Mark W. Eshoo, PhD, is Director, New Technology Development; Kristin A. Sannes-Lowery, PhD, is Director of Commercial Laboratory Operations; and Steven A. Hofstadler, PhD, is Divisional Vice President, Research and Development; all at Ibis Biosciences, Inc., An Abbott Company, Carlsbad, California. Cassie L. Redden, BS, was, at the time this article was written, Research Associate; James P. Burans, PhD, is Director; and M. J. Rosovitz, PhD, is Principal Investigator; all at the National Bioforensic Analysis Center, National Biodefense Analysis and Countermeasures Center, Frederick, Maryland","National Bioforensic Analysis Center, National Biodefense Analysis and Countermeasures Center, Frederick, Maryland","New Technology Development;","S. Timothy Motley, MS, is Principal Scientist, New Technology Development; Mark W. Eshoo, PhD, is Director, New Technology Development; Kristin A. Sannes-Lowery, PhD, is Director of Commercial Laboratory Operations; and Steven A. Hofstadler, PhD, is Divisional Vice President, Research and Development; all at Ibis Biosciences, Inc., An Abbott Company, Carlsbad, California. Cassie L. Redden, BS, was, at the time this article was written, Research Associate; James P. Burans, PhD, is Director; and M. J"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"S. Timothy Motley, MS, is Principal Scientist, New Technology Development; Mark W. Eshoo, PhD, is Director, New Technology Development; Kristin A. Sannes-Lowery, PhD, is Director of Commercial Laboratory Operations; and Steven A. Hofstadler, PhD, is Divisional Vice President, Research and Development; all at Ibis Biosciences, Inc., An Abbott Company, Carlsbad, California. Cassie L. Redden, BS, was, at the time this article was written, Research Associate; James P. Burans, PhD, is Director; and M. J. Rosovitz, PhD, is Principal Investigator; all at the National Bioforensic Analysis Center, National Biodefense Analysis and Countermeasures Center, Frederick, Maryland","institution_ids":["https://openalex.org/I4210088555"]},{"raw_affiliation_string":"National Bioforensic Analysis Center, National Biodefense Analysis and Countermeasures Center, Frederick, Maryland","institution_ids":[]},{"raw_affiliation_string":"New Technology Development;","institution_ids":[]},{"raw_affiliation_string":"S. Timothy Motley, MS, is Principal Scientist, New Technology Development; Mark W. Eshoo, PhD, is Director, New Technology Development; Kristin A. Sannes-Lowery, PhD, is Director of Commercial Laboratory Operations; and Steven A. Hofstadler, PhD, is Divisional Vice President, Research and Development; all at Ibis Biosciences, Inc., An Abbott Company, Carlsbad, California. Cassie L. Redden, BS, was, at the time this article was written, Research Associate; James P. Burans, PhD, is Director; and M. J","institution_ids":["https://openalex.org/I4210088555"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210088555"],"apc_list":null,"apc_paid":null,"fwci":0.1497,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":{"value":0.44995972,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":"11","issue":"2","first_page":"107","last_page":"117"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10683","display_name":"Mass Spectrometry Techniques and Applications","score":0.8065999746322632,"subfield":{"id":"https://openalex.org/subfields/1607","display_name":"Spectroscopy"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10683","display_name":"Mass Spectrometry Techniques and Applications","score":0.8065999746322632,"subfield":{"id":"https://openalex.org/subfields/1607","display_name":"Spectroscopy"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T12167","display_name":"Bacterial Identification and Susceptibility Testing","score":0.12370000034570694,"subfield":{"id":"https://openalex.org/subfields/1308","display_name":"Clinical Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11515","display_name":"Bacillus and Francisella bacterial research","score":0.01600000075995922,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/microbial-forensics","display_name":"forensic microbiology","score":0.9509999752044678},{"id":"https://openalex.org/keywords/electrospray-ionization-mass-spectrometry","display_name":"electrospray ionization mass spectrometry","score":0.8920000195503235},{"id":"https://openalex.org/keywords/biological-threat-agents","display_name":"biothreat agents","score":0.6399999856948853}],"concepts":[{"id":"https://openalex.org/C8185291","wikidata":"https://www.wikidata.org/wiki/Q2844457","display_name":"Amplicon","level":4,"score":0.90855872631073},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.5768248438835144},{"id":"https://openalex.org/C40684141","wikidata":"https://www.wikidata.org/wiki/Q902061","display_name":"Electrospray ionization","level":3,"score":0.5654836297035217},{"id":"https://openalex.org/C2778545548","wikidata":"https://www.wikidata.org/wiki/Q4914739","display_name":"Biodefense","level":2,"score":0.5233166217803955},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.5188187956809998},{"id":"https://openalex.org/C2777563447","wikidata":"https://www.wikidata.org/wiki/Q7243397","display_name":"Primer (cosmetics)","level":2,"score":0.4763215482234955},{"id":"https://openalex.org/C162356407","wikidata":"https://www.wikidata.org/wiki/Q180809","display_name":"Mass spectrometry","level":2,"score":0.45382535457611084},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.45241519808769226},{"id":"https://openalex.org/C49105822","wikidata":"https://www.wikidata.org/wiki/Q176996","display_name":"Polymerase chain reaction","level":3,"score":0.4424207806587219},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.38344985246658325},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.32635048031806946},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.26372456550598145},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.197967529296875},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.13692530989646912},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D004269","descriptor_name":"DNA, Bacterial","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":true},{"descriptor_ui":"D006090","descriptor_name":"Gram-Negative Bacteria","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D012367","descriptor_name":"RNA, Viral","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":true},{"descriptor_ui":"D012680","descriptor_name":"Sensitivity and Specificity","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020133","descriptor_name":"Reverse Transcriptase Polymerase Chain Reaction","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D020641","descriptor_name":"Polymorphism, Single Nucleotide","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D021241","descriptor_name":"Spectrometry, Mass, Electrospray Ionization","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D023482","descriptor_name":"Bioterrorism","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D044707","descriptor_name":"Forensic Sciences","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D045404","descriptor_name":"Hendra Virus","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D045405","descriptor_name":"Nipah Virus","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D047971","descriptor_name":"Clostridium botulinum type F","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D060888","descriptor_name":"Real-Time Polymerase Chain Reaction","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.1089/bsp.2012.0062","doi":"https://doi.org/10.1089/bsp.2012.0062","is_oa":true,"landing_page_url":"https://doi.org/10.1089/bsp.2012.0062","pdf_url":null,"source":{"id":"https://openalex.org/S167979021","display_name":"Biosecurity and Bioterrorism Biodefense Strategy Practice and Science","issn_l":"1538-7135","issn":["1538-7135","1557-850X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","jufo-1","norway-1"],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biosecurity and Bioterrorism: Biodefense Strategy, Practice, and Science","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:2700497","doi":null,"is_oa":true,"landing_page_url":"http://europepmc.org/articles/PMC3696942","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"","raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:3696942","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3696942","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biosecur Bioterror","raw_type":"Text"},{"id":"pmid:23675878","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23675878","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biosecurity and bioterrorism : biodefense strategy, practice, and science","raw_type":"Evaluation Study"}],"best_oa_location":{"id":"doi:10.1089/bsp.2012.0062","doi":"https://doi.org/10.1089/bsp.2012.0062","is_oa":true,"landing_page_url":"https://doi.org/10.1089/bsp.2012.0062","pdf_url":null,"source":{"id":"https://openalex.org/S167979021","display_name":"Biosecurity and Bioterrorism Biodefense Strategy Practice and Science","issn_l":"1538-7135","issn":["1538-7135","1557-850X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","jufo-1","norway-1"],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biosecurity and Bioterrorism: Biodefense Strategy, Practice, and Science","raw_type":"journal-article"},"sustainable_development_goals":[],"study_designs":[],"awards":[{"id":"https://openalex.org/G1093785223","display_name":null,"funder_award_id":"HSHQDC-07-C-00020","funder_id":"https://openalex.org/F4320306110","funder_display_name":"U.S. Department of Homeland Security"}],"funders":[{"id":"https://openalex.org/F4320306110","display_name":"U.S. Department of Homeland Security","ror":"https://ror.org/00jyr0d86"},{"id":"https://openalex.org/F4320306493","display_name":"Abbott Laboratories","ror":"https://ror.org/0052svj16"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":15,"referenced_works":["https://openalex.org/W2006753593","https://openalex.org/W2012080636","https://openalex.org/W2016311625","https://openalex.org/W2020997133","https://openalex.org/W2034669798","https://openalex.org/W2060857484","https://openalex.org/W2070141130","https://openalex.org/W2076421078","https://openalex.org/W2093735248","https://openalex.org/W2097959223","https://openalex.org/W2104032502","https://openalex.org/W2109971578","https://openalex.org/W2117834016","https://openalex.org/W2119107074","https://openalex.org/W2142158617"],"related_works":["https://openalex.org/W7095394535","https://openalex.org/W2093572951","https://openalex.org/W1997208744","https://openalex.org/W2070925560","https://openalex.org/W25847692","https://openalex.org/W2410943186","https://openalex.org/W2079974509","https://openalex.org/W2899617610","https://openalex.org/W3022021437","https://openalex.org/W7203465864"],"abstract_inverted_index":{"Molecular":[0],"bioforensic":[1],"research":[2],"is":[3,36,63,176],"dependent":[4],"on":[5],"rapid":[6],"and":[7,33,51,72,99,107,109,161,165,180,197,228,240],"sensitive":[8],"methods":[9,89,190],"such":[10],"as":[11],"real-time":[12],"PCR":[13],"(qPCR)":[14],"for":[15,117,178,188,230],"the":[16,31,43,49,76,163,169,186,212,231],"identification":[17],"of":[18,22,42,84,131,168,171,199,204,214],"microorganisms.":[19],"The":[20,154],"use":[21,116],"synthetic":[23,151],"positive":[24,70,144,152,238,242],"control":[25,239],"templates":[26],"containing":[27],"small":[28,205],"modifications":[29],"outside":[30],"primer":[32],"probe":[34,78],"regions":[35],"essential":[37],"to":[38,91,105,137,159,191,233],"ensure":[39],"all":[40],"aspects":[41],"assay":[44,62],"are":[45,86],"functioning":[46],"properly,":[47],"including":[48,94,195],"primers":[50],"probes.":[52],"However,":[53],"a":[54,128,172,237,241],"typical":[55],"qPCR":[56,60,140,160,193,220],"or":[57,202],"reverse":[58],"transcriptase":[59],"(qRT-PCR)":[61],"limited":[64],"in":[65],"differentiating":[66],"products":[67],"generated":[68,80,142,149],"from":[69,81,147],"controls":[71],"biological":[73,145],"samples":[74,146],"because":[75],"fluorescent":[77],"signals":[79],"each":[82],"type":[83],"amplicon":[85,100],"indistinguishable.":[87],"Additional":[88],"used":[90],"differentiate":[92,139],"amplicons,":[93],"melt":[95],"curves,":[96],"secondary":[97,200],"probes,":[98],"sequencing,":[101],"require":[102],"significant":[103],"time":[104],"implement":[106],"validate":[108],"present":[110],"technical":[111],"challenges":[112],"that":[113,175],"limit":[114],"their":[115],"microbial":[118,218],"forensic":[119,219],"applications.":[120],"To":[121],"solve":[122],"this":[123,208,215],"problem,":[124],"we":[125,210],"have":[126],"developed":[127],"novel":[129],"application":[130],"electrospray":[132],"ionization":[133],"mass":[134],"spectrometry":[135],"(ESI-MS)":[136],"rapidly":[138,234],"amplicons":[141],"with":[143,150,217],"those":[148],"controls.":[153],"method":[155],"has":[156],"sensitivity":[157],"equivalent":[158],"supports":[162],"confident":[164],"timely":[166],"determination":[167],"presence":[170],"biothreat":[173],"agent":[174],"crucial":[177],"policymakers":[179],"law":[181],"enforcement.":[182],"Additionally,":[183],"it":[184],"eliminates":[185],"need":[187],"time-consuming":[189],"confirm":[192],"results,":[194],"development":[196],"validation":[198],"probes":[201],"sequencing":[203],"amplicons.":[206],"In":[207],"study,":[209],"demonstrate":[211],"effectiveness":[213],"approach":[216],"assays":[221],"targeting":[222],"multiple":[223],"biodefense":[224],"agents":[225],"(bacterial,":[226],"viral,":[227],"toxin)":[229],"ability":[232],"discriminate":[235],"between":[236],"sample.":[243]},"counts_by_year":[{"year":2018,"cited_by_count":1},{"year":2016,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}